Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 151-156, April 2010

Forkhead box M1 transcription factor: A novel target for cancer therapy

Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States

Received 14 October 2009; received in revised form 9 November 2009; accepted 15 November 2009. published online 21 December 2009.

Summary 

FoxM1 signaling has been reported to be associated with carcinogenesis. Therefore, the FoxM1 may represent a novel therapeutic target, and thus the development of agents that will target FoxM1 is likely to have significant therapeutic impact on human cancer. This review describes the mechanisms of signal transduction associated with FoxM1 and provides emerging evidence in support of its role in the carcinogenesis. Further, we summarize data on several FoxM1 inhibitors especially “chemopreventive agents” and these agents could be useful for targeted inactivation of FoxM1, which indeed could become a novel approach for the prevention and/or treatment of human cancer.

Keywords: FoxM1, Cancer, Cell signaling pathway, Chemopreventive agents

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(09)00180-7

doi:10.1016/j.ctrv.2009.11.006

Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 151-156, April 2010